The catalogue of medical devices was adjusted to promote the standardized development of the medical and aesthetic industry
This week (March 30), the State Food and drug administration adjusted the classified catalogue of medical devices (hereinafter referred to as the catalogue), included “Shuiguang needle” and other products into the management of class III medical devices, and further clarified the composition and purpose of the products.
“Shuiguang needle” usually refers to a kind of composite solution product with sodium hyaluronate as the main component. It produces effect by injecting it into the dermis. It has been loved by consumers for a long time due to its low price, diverse effects and short recovery period. However, at present, there are a large number of irregularities in China’s Shuiguang needle Market: on the one hand, most products have not obtained the registration certificate of class III medical devices; On the other hand, many unqualified beauty salons operate injections in violation of regulations for profit, which also brings great potential safety hazards. Industry chaos forced the strengthening of supervision. We believe that the adjustment of the catalogue will have a significant impact on the upstream and downstream of the medical and American industry: (1) from the perspective of medical and American institutions, under strict supervision, institutions will further reduce the use of non-conforming products and promote the purchase demand of relevant compliant products in the short term; (2) From the perspective of manufacturers, after the positioning of Shuiguang needle is clear, major manufacturers will also accelerate the application of products, strive to obtain certificates and launch products early, and enjoy the compliance market dividend period; (3) The consumer education catalogue will be further adjusted. In addition, since March, the epidemic has had a great impact on offline medical and American consumption. In comparison, leading institutions have stronger anti risk ability. We believe that the trend of tightening the supervision of the medical beauty industry remains unchanged. With the development of industry norms, the clearance of non-conforming products and institutions will be accelerated, and the leaders of compliant medical beauty products and institutions are expected to benefit significantly.
Industry Keywords: Shihui group, community Jidan, Shuiguang needle, state stick, famous and innovative products, etc
[Shihui group] Shihui group, a community group purchase platform, shut down all businesses in the country.
[community collection list] HEMA’s “community collection list” has covered 756 communities in Shanghai.
[Shuiguang needle] the food and drug administration has included “Shuiguang needle” and other medical and American products into the supervision of class III medical devices.
[status bar] Alibaba tested the “status bar” e-commerce app.
[Famous and excellent products] famous and excellent products submit their listing application to the Hong Kong stock exchange.
Plate Market Review
This week (from March 28 to April 1), the retail trade index closed at 271801 points, up 3.93%, outperforming the Shanghai Composite Index (up 2.19% this week) by 1.73 percentage points, ranking sixth among the 31 primary industries. Among the retail segments, the multi format retail segment performed better this week, with the largest increase in the commercial property operation segment since the beginning of 2022. In terms of individual stocks, this week Hangzhou Lianluo Interactive Information Technology Co.Ltd(002280) (21.7%), China National Complete Plant Import And Export Co.Ltd(000151) (16.3%), Nanning Department Store Co.Ltd(600712) (13.5%) rose ahead.
Investment suggestion: focus on cosmetics, medical beauty, gold jewelry and supermarket
Investment main line 1 (cosmetics): continuous verification of large single product + multi-channel logic, focusing on recommending domestic beauty leaders Yunnan Botanee Bio-Technology Group Co.Ltd(300957) , Proya Cosmetics Co.Ltd(603605) , Lushang Health Industry Development Co.Ltd(600223) , and cosmetics raw materials leaders of beneficiary objects Nanjing Cosmos Chemical Co.Ltd(300856) etc;
Investment main line 2 (medical beauty): focus on recommending the leading products of medical beauty Imeik Technology Development Co.Ltd(300896) , the layout of the whole industrial chain Bloomage Biotechnology Corporation Limited(688363) ;
Investment main line 3 (gold jewelry and supermarket): pay attention to the increase of the market share of gold jewelry head brands, and focus on DEA shares, Guangdong Chj Industry Co.Ltd(002345) , Chow Tai Seng Jewellery Company Limited(002867) . In addition, pay attention to the marginal improvement of the operation of supermarket enterprises.
Repeated outbreaks, industry risks, etc.
